Investment

Details

Screening Program
  • RFP Year
    2017
  • Awarded Amount
    $65,836
  • Disease
    Malaria
  • Intervention
    Drug
  • Development Stage
    Hit Identification
  • Collaboration Partners
    Astellas Pharma Inc., Medicines for Malaria Venture (MMV)